Pharmafile Logo

Live Webinar: Poker face revealed: Using facial analysis to reveal deeper emotional insights

Thursday 28th February 2019, 10:00 EST / 15:00 GMT / 16:00 CET

Thursday 28th February 2019
10:00 EST / 15:00 GMT / 16:00 CET
Register now to secure your place » 

Does your expression give you away? According to psychologists, a lot of emotional information can be drawn from our facial expressions. Brief, involuntary flashes of emotion or ‘micro-expressions’ can reveal a lot about a person’s true feelings. As market researchers interested in the emotional responses driving people’s attitudes and behaviours, this information is invaluable but can often be difficult to obtain. One of the latest innovations in market research is facial analysis, which uses recognition software to detect a range of emotions in faces.

Register now to secure your place » 

Join us for this complimentary webinar event hosted in partnership with emotion measurement company, Affectiva, which has analysed over 5,000,000 faces and 24,000 adverts to understand how people respond to digital stimulus such as advertisements, websites and smartphone apps. We will demonstrate how, over the past several years, we’ve been using facial analysis in both qualitative and quantitative settings to delve further into respondents’ reactions to healthcare communications.

What are the key takeaways?

The theory
Learn more about the science and technology underpinning facial and emotional analysis.

Applications in healthcare MRX
Discover how we used facial analysis to deliver additional insights in a pharmaceutical setting.

Key considerations
Find out about the logistical challenges of using this methodology and how to overcome them.

Looking forwards
Explore future applications of facial analysis including integration with other technologies.

Gain answers to your key questions
At the end of the webinar there will be a live Q&A session. Start the conversation by submitting your questions in advance when you register.

Thursday 28th February 2019
10:00 EST / 15:00 GMT / 16:00 CET
Register now to secure your place »

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Infographic: Rare Diseases in China

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.

Man vs microbe: the fight against antimicrobial resistance

How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics.

Research Partnership Senior Director Andrew Stokes appointed new role as Chief Commercial Officer

With over 20 years' experience in the industry, Research Partnership Senior Director and market research veteran Andrew Stokes has been appointed Chief Commercial Officer.

Case study: How we enhanced the power of a global ATU using our advanced analytics solution, Equity AI

Find out how we provided a more holistic understanding of brand equity and a forward indication of potential market share using our advanced analytics solution, Equity AI.

Article: Creating truly effective communications – the impact of high speed, high octane messaging

In a recent interview for PME Magazine, Roy Rogers shows how to navigate the busy omnichannel communication lanes to make the best of digital.

Research Partnership makes two senior appointments to bolster its US and MedTech operations

Research Partnership is delighted to announce the appointments of Sue Wild as President, US Pharma in the US and Tom Donnelly as a Director in the US MedTech division.

Case study: How segmentation of treaters guided a novel product launch in the allergy space

Find out how we helped our client to obtain an intuitive and actionable segmentation in order to drive market shaping activities ahead of their product launch aimed at the treatment...

Article: War in the Blood – The battle takes shape in the burgeoning European oncology CAR-T market access space

Tania Rodrigues investigates the market access and commercialization potential for manufacturers of CAR-T therapies in the latest issue of pharmaphorum's Deep Dive.